Treosulfan-induced myalgia in pediatric hematopoietic stem cell transplantation identified by an electronic health record text mining tool
Abstract Treosulfan is increasingly used as myeloablative agent in conditioning regimen prior to allogeneic hematopoietic stem cell transplantation (HSCT). In our pediatric HSCT program, myalgia was regularly observed after treosulfan-based conditioning, which is a relatively unknown side effect. Us...
Guardado en:
Autores principales: | M. Y. Eileen C. van der Stoep, Dagmar Berghuis, Robbert G. M. Bredius, Emilie P. Buddingh, Alexander B. Mohseny, Frans J. W. Smiers, Henk-Jan Guchelaar, Arjan C. Lankester, Juliette Zwaveling |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/32df6957af434a298b3c729660b8644e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rare presentation of Graves’ disease with myalgia: A case report
por: Masaru Kurihara, et al.
Publicado: (2021) -
Docetaxel-associated myalgia–arthralgia syndrome in patients with breast cancer
por: Seguin C, et al.
Publicado: (2017) -
Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006.
por: Mariam Molokhia, et al.
Publicado: (2008) -
Associations of statin use with motor performance and myalgia may be modified by 25-hydroxyvitamin D: findings from a British birth cohort
por: Nikhil Sharma, et al.
Publicado: (2017) -
Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications.
por: Ana Teresa Amaral, et al.
Publicado: (2014)